Covid Drug – FDA Approval Phase Three Trial Begins Shares Soar – Revive Therapeutics RVV CSE – RVVTF OTC

Traders Pick – Corp Update – STOCK SOARS 20% Shares Triple since March – These shares are actively traded. Serious Investors should place these shares on their BUY LIST Phase Three Clinical Trials Gets FDA Approval CORP UPDATE TORONTO, July 31, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV) (OTCQB:…